XML 52 R35.htm IDEA: XBRL DOCUMENT v3.26.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Significant Expense Categories (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]    
Total license fee revenue $ 1,300 $ 200
General and administrative expense    
Other income (expense) (5,028) 2,019,022
Gain related to transaction with Acquirer 0 2,021,498
Net income (loss) (140,055) 1,687,572
Reportable Segment    
Segment Reporting Information [Line Items]    
Total license fee revenue 1,300 200
Research and development expense    
Personnel 35,372 72,790
Clinical trials 35,339 47,665
Contract manufacturing 19,590 55,643
Equipment, depreciation, and facility 10,227 9,693
Other research and development 12,500 17,952
General and administrative expense    
Merger-related 0 68,061
Personnel 14,481 37,649
Other general and administrative 8,816 22,195
Other income (expense) (5,028) (2,476)
Gain related to transaction with Acquirer 0 2,021,498
Other segment expenses 2 2
Net income (loss) $ (140,055) $ 1,687,572